CVS - CVS Health Corporation
55.20 -0.19 (-0.34%)
After hours: 7:47PM EDT
| Previous Close | 54.95 |
| Open | 55.38 |
| Bid | 55.01 x 800 |
| Ask | 55.38 x 800 |
| Day's Range | 55.08 - 56.17 |
| 52 Week Range | 51.93 - 82.15 |
| Volume | 11,730,949 |
| Avg. Volume | 13,059,518 |
| Market Cap | 71.845B |
| Beta (3Y Monthly) | 1.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.57 |
| Earnings Date | Apr 30, 2019 - May 6, 2019 |
| Forward Dividend & Yield | 2.00 (3.57%) |
| Ex-Dividend Date | 2019-04-22 |
| 1y Target Est | 76.76 |
- Yahoo Finance Video•6 hours ago
What are the healthiest communities in America?
Yahoo Finance's Zack Guzman and Seana Smith are joined by Beth Comstock, Former GE Vice Chair, “Imagine it Forward” author to discuss the healthiest communities in America with Dr. Garth Graham, Aetna Foundation president.
- Yahoo Finance Video•4 days ago
Produce with the most pesticides in your grocery store
In this week's Family First segment on YFI PM, we break down new concerns over kale, tax refunds, and the latest break-through for postpartum depression.
- GlobeNewswire•4 hours ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DPLO, CVS, UMC and CNDT
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
- Zacks•5 hours ago
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, CVS Health (CVS) closed at $55.50, marking a +1% move from the previous day.
- ACCESSWIRE•5 hours ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadline – CVS
NEW YORK, NY / ACCESSWIRE / March 26, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (''CVS'' or the ''Company'') (CVS) and certain of its officers and directors. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01725, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the ''Class Period''), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- Zacks•8 hours ago
Better Buy Amid Tech Diversification: Apple (AAPL) vs. Amazon (AMZN) Stock
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
- ACCESSWIRE•10 hours ago
CLASS ACTION UPDATE for ASTE, DPLO and CVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / March 26, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- GlobeNewswire•11 hours ago
CVS DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against CVS Health Corporation – CVS
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of CVS Health Corporation (CVS) from May 21, 2015 through February 20, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for CVS investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than April 26, 2019.
- Investing.com•12 hours ago
Cigna Shares Hit 52-Week Low on Trump Bid to Kill ACA
Investing.com - The Trump Administration wants the entire Affordable Care Act (also known as Obamacare) declared unconstitutional and Cigna (NYSE:CI) shares fell back Tuesday as a result.
- Motley Fool•12 hours ago
Biogen's Bad News for Everyone
The biotech nosedives after disappointing results for everyone involved in the Alzheimer's space.
- Market Realist•15 hours ago
Amazon Challenges Walgreens and CVS Health Again
How Amazon and Alibaba Are Facing Competition(Continued from Prior Part)Amazon not done shaking up the pharmacy space Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of
- American City Business Journals•yesterday
More space, more locations: How one fitness tenant is defying the typical S.F. retail narrative
The tenant just opened its largest location to date in one of the most expensive — yet challenging — neighborhoods in San Francisco.
- Insider Monkey•yesterday
Were Hedge Funds Right About CVS Health Corporation (CVS)?
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a torrid quarter, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As […]
- Motley Fool•yesterday
3 Top Healthcare Stocks to Buy Right Now
What do a beaten-down biotech, a giant pharmacy chain, and a robotic surgical systems maker have in common? They could all be great stocks to buy.
- GlobeNewswire•yesterday
SHAREHOLDER ALERT: GE MHLD KHC CVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, March 25, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
- GlobeNewswire•yesterday
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CVS, KHC, CTL, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, March 25, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
- GlobeNewswire•yesterday
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVP, VNDA, CVS and INGN
NEW YORK, March 25, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
- Motley Fool•2 days ago
It's Official: I Now Own a Pot Stock... Sort Of
The nation's largest pharmacy chain rolls out the red carpet for cannabis-based products in eight states.
- Market Realist•2 days ago
What Drove Curaleaf’s Stock Price Last Week?
What Drove Curaleaf’s Stock Price Last Week?Sector performance On March 22, the US market fell on concerns over global growth prospects as the yield on long-term bonds, such as the ten-year Treasury note, fell below that of short-term bonds, such
- GlobeNewswire•2 days ago
Investor Expectations to Drive Momentum within CVS Health, KKR & Co., ConocoPhillips, MetLife, Rockwell Automation, and Norfolk Southern — Discovering Underlying Factors of Influence
NEW YORK, March 25, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
- Motley Fool•2 days ago
Don’t Judge CVS Health by Its Stores
They represent less than 10% of the company’s revenue, and that percentage is set to shrink.
- Motley Fool•4 days ago
The Smartest People on Wall Street Are Buying These 3 Stocks -- Should You Follow?
The smart money is buying these three stocks, but does that make them right for your portfolio? It's a matter of balancing risk and reward...
- GlobeNewswire•4 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF Reminds CVS, WTW, CTL, BPI Investors of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, March 22, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
- American City Business Journals•4 days ago
Three Alabama colleges receive grants from CVS Health
CVS Health will be presenting three Alabama colleges with grants to advocate for, adopt and implement smoke- and tobacco- free campus policies. Lawson State Community College in Birmingham, Lurleen B. Wallace Community College and Andalusia and the University of West Alabama in Livingston will receive a total of $59,786 in grants from the CVS Health Foundation. “A critical goal in building healthier communities across the country is reducing tobacco-use, which remains one of the leading causes of preventable death in this country,” said Eileen Howard Boone, president of the CVS Health Foundation.
- InvestorPlace•4 days ago
CVS to Sell CBD Products in 800 Stores — What and Where?
CVS (NYSE:CVS) announced that it will soon start selling CBD products in 800 stores and eight states.Source: Mike Mozart via FlickrCBD refers to cannabidiol, which is a hemp-based product that is part of the cannabis family, but differs from marijuana as the latter has TCH, which is the psychoactive chemical in the plant. Meanwhile, CBD is not psychoactive, meaning it does not incapacitate it users and may have medicinal benefits.CVS said Wednesday that it will start selling CBD products, including creams, sprays and roll-ons, which will serve as "an alternative source of relief." Some believe the substance helps with anxiety, pain, inflammation and cancer, although the research to back up this claims is anecdotal-the only FDA-backed CBD oil helps with seizures for severe forms of epilepsy.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options," said CVS Health Spokesperson, Mike DeAngelis. The company will partner up with a company to test the quality of the CBD products available in its drug stores.Only consumers in the states of Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee will have access to these products at their local CVS locations at first. Claims surrounding how effective these CVS CBD products are will vary from item to item.CVS stock is down about 1.6% on Friday following the news. More From InvestorPlace * 5 Cloud Stocks to Help Your Portfolio Fly * 10 Stocks on the Rise Heading Into the Second Quarter * 7 Beaten-Up Stocks to Buy as They Reverse Course Compare Brokers The post CVS to Sell CBD Products in 800 Stores -- What and Where? appeared first on InvestorPlace.
